Gastric Cancer
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2007; 13(32): 4321-4327
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4321
Table 1 Correlation between pathology and syndrome differentiation in 419 cases of gastric carcinoma
ItemsSyndrome differentiation
AllP
IBLSSPDIOSTDCSSYISHDOQB
(n)1488474462938419
SexM9964573411212860.001
W492017121817133
Age (yr)<401197322340.894
≥ 401377567432736385
PCSquamous carcinoma1000001
adenoma12270643926363570.277
Mucoid adenoma103742228
Signet-ring1511331033
ASI (I-II)22101170.899
II (II-III)754138311620221
III (III-IV)703834141216184
IV1311017
In12156222380.298
2322421116498
351222920915146
4443318131217137
LNMNo503028169131460.989
Yes985446302025273
DM011664583719313250.676
1322016910794
CSI42201810461000.216
II18131676464
IIIa-IIIb482222201013135
IV4029189915120
TSLump2516181178850.278
Ulcer19151247764
Ulcerative lump824439301321229
LB stomach4101129
Local mucous lesion188501032
TLFundal cardia789544370.452
Body573433241118177
Antrum/pylorus793831151216191
Multiple54122014
Table 2 E-cad immunohistochemical expression values in different syndrome differentiation types of gastric carcinoma
SD in TCMnE-cad expression value
SPD (1)1766960466696368963
YISH (2)1626604822428641241
IOST (3)1600612603033208144
DOQB (4)17646886212964440689
DCSS (5)176641246896824112244
IBLS (6)17012202321641626240
Table 3 Comparison of E-cad expression values and SD in TCM
Comparison groupsχ2PComparison groupsχ2P
1, 288.434< 0.012, 660.018< 0.01
1, 3264.674< 0.013, 4265.648< 0.01
1, 40.001> 0.053, 5193.162< 0.01
1, 56.021> 0.053, 60.697> 0.05
1, 6303.01< 0.014, 55.936> 0.05
2, 346.373< 0.014, 6302.395< 0.01
2, 488.107< 0.015, 6223.599< 0.01
2, 548.806< 0.01
Table 4 ICAM-1 immunhistochemical expression values in different SD types
SD typenICAM-1
SPD1700011160011211121
YISH161020102101212011
IOST162040201111104141
DOQB1700101011001002061
DCSS1711111000121010001
IBLS1700000100040210100